Hungary's export-dependent drugmakers face earnings pressure from strong forint

5 articles · Updated · Bloomberg · Apr 30

Gedeon Richter chief executive Gabor Orban said the currency's rapid appreciation is hurting the Hungarian pharmaceutical group's overseas income.
He said the forint's strength, rather than lower short-term interest rates, is driving easier financial conditions after Hungary's post-election market rally.
The warning highlights a broader risk for Hungarian exporters, whose foreign-currency revenues lose value when converted into a stronger domestic currency.

Is Hungary's new government trading short-term export pain for the long-term stability of adopting the euro?

With a strong forint and high inflation, is the central bank trapped between saving exporters and controlling prices?